Found vs Oak Longevity: Personalized Care vs Flat-Price Compounds
Found vs Oak Longevity quickly comes down to approach: Found emphasizes a biology-first, personalized medically supervised program with plans starting at as low as $39, while Oak Longevity focuses on low flat pricing for compounded GLP-1s, with semaglutide from $133/month and tirzepatide from $199/month. Early verdict: choose Found if you want a holistic, insurance-facing program built around metabolic biology; choose Oak Longevity if you want the lowest flat monthly price for compounded semaglutide or tirzepatide with no membership required.
Explore Found plans starting as low as $39
How they differ: personalization, pricing, and membership
Found and Oak Longevity both offer GLP-1 access in telehealth formats, but the evidence highlights three distinctive differences: Found centers on a biology-first personalized program and insurance integration, while Oak Longevity promotes one flat price for all dosages and no subscriptions. Found advertises flexible, affordable monthly plans and insurance handling; Oak advertises semaglutide from $133/month and tirzepatide from $199/month with free shipping and free health coaching.
1. Program model and clinical review
Found offers a personalized medically supervised program that evaluates hormones, blood sugar regulation, sleep, and behavior to tailor care. Oak Longevity operates with an online health questionnaire and asynchronous clinician review; Oak notes board-certified physicians review every case and no video call is required. Both state that prescriptions are subject to clinician review and clinical eligibility.
2. Pricing and membership structure
Found highlights “get started for as low as $39” and emphasizes “most insurance now accepted” and affordability with flexible pricing and cancel anytime options. Oak Longevity advertises semaglutide from $133/month and tirzepatide from $199/month, one flat price for all dosages, billed monthly on a non-recurring basis with no subscription or membership fees.
3. Medication format and regulatory notes
Both providers offer compounded GLP-1 medications. The evidence for each preserves the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Found also references branded GLP-1s and notes some medications are FDA-approved for conditions other than weight and includes statements about insurance commitments for branded GLP-1s in certain plans. Oak emphasizes compounded semaglutide and tirzepatide and gives eligibility notes such as BMI thresholds.
Quick comparison table
| Criteria | Found | Oak Longevity |
|---|---|---|
| Approach | Biology-first personalized medically supervised program | Flat-price compounded GLP-1s with online questionnaire |
| Starting price | Get started for as low as $39 | Semaglutide from $133/mo; tirzepatide from $199/mo |
| Membership | Affordable monthly plans; insurance handled; cancel anytime noted | No subscriptions or membership fees; billed non-recurring monthly |
| Medication type | Compounded and branded GLP-1 options referenced; Rx subject to provider review | Compounded semaglutide and tirzepatide; one price covers all dosages |
| Shipping and extras | Insurance paperwork handled by Found; programs mention various plan structures | Free shipping with tracking and free health coaching included |
Other practical differences from the evidence
Found highlights insurance acceptance and resources for Medicare Part D access in some branded-GLP-1 scenarios and mentions offers and membership tiers. Oak Longevity stresses no auto renewals, three-month prescriptions billed upfront when chosen, same-day approval for qualifying patients, and that no refunds are available after physician approval and once medication has shipped. Oak also notes patients with BMI below 20 or under certain thresholds may not qualify, and some age and pregnancy restrictions are called out in captured pros and cons.
See Found’s biology-first plans and insurance options
Check Oak Longevity’s flat-price semaglutide and tirzepatide
Safety and eligibility notes
Both providers include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Found and Oak both state prescriptions are subject to provider review and clinical eligibility. Oak’s evidence includes BMI eligibility guidance for GLP-1 treatment and notes that compounded products are prepared by licensed compounding pharmacies.
Found vs Oak Longevity: final thoughts
Found vs Oak Longevity is a choice between a personalized, insurance-integrated, biology-first program and a low flat-price, no-membership compounded medication path. Found emphasizes comprehensive metabolic evaluation and insurance handling with plans starting as low as $39. Oak Longevity emphasizes low, consistent monthly pricing for compounded semaglutide and tirzepatide from $133/month and $199/month respectively, with no subscription required and free shipping and coaching.
Compare Oak Longevity pricing and terms
Choose Found if…
You want a medically supervised, biology-first weight-loss program that targets hormones, metabolism, sleep, and behavior, and you value insurance handling and flexible monthly plans starting at as low as $39. Found may also offer branded GLP-1 access and insurance-supported pricing in some scenarios, subject to eligibility and provider review.
Choose Oak Longevity if…
You are cost-conscious and want one flat price for compounded semaglutide or tirzepatide with no subscription or membership fees, free shipping and coaching, and an asynchronous clinician review process where you renew payments month to month rather than joining a membership.